AdE-1, a cardiotonic peptide recently isolated from the sea anemone Aiptasia diaphana, contains 44 amino acids and has a molecular mass of 4907 Da. It was previously found to resemble other sea anemone type 1 and 2 Na + channel toxins, enhancing contractions of rat cardiomyocytes and slowing their twitch relaxation; however, it did not induce spontaneous twitches. AdE-1 increased the duration of the cardiomyocyte action potential and decreased its amplitude and its time-to-peak in a concentrationdependent manner, without affecting its threshold and cell resting potential. Nor did it generate the early and delayed afterdepolarizations characteristic of sea anemone Na + channel toxins. To further understand its mechanism of action we investigated the effect of AdE-1 on the major ion currents of rat cardiomyocytes. In the present study we show that AdE-1 markedly slowed inactivation of the Na + current, enhancing and prolonging the current influx with no effect on current activation, possibly through direct interaction with the site 3 receptor of the Na + channel. No significant effect of AdE-1 on the Ca 2 + current was observed, but, unexpectedly, AdE-1 significantly increased the amplitude of the transient component of the K + current, shifting the current threshold to more negative membrane potentials. This effect on the K + current has not been found in any other sea anemone toxin and may explain the exclusive reduction in action potential amplitude and the absence of the action potential disorders found with other toxins, such as early and delayed afterdepolarizations.
The sea anemone toxin AdE-1 modifies both sodium and potassium currents of rat cardiomyocytes Nir AdE-1, a cardiotonic peptide recently isolated from the sea anemone Aiptasia diaphana, contains 44 amino acids and has a molecular mass of 4907 Da. It was previously found to resemble other sea anemone type 1 and 2 Na + channel toxins, enhancing contractions of rat cardiomyocytes and slowing their twitch relaxation; however, it did not induce spontaneous twitches. AdE-1 increased the duration of the cardiomyocyte action potential and decreased its amplitude and its time-to-peak in a concentrationdependent manner, without affecting its threshold and cell resting potential. Nor did it generate the early and delayed afterdepolarizations characteristic of sea anemone Na + channel toxins. To further understand its mechanism of action we investigated the effect of AdE-1 on the major ion currents of rat cardiomyocytes.
In the present study we show that AdE-1 markedly slowed inactivation of the Na + current, enhancing and prolonging the current influx with no effect on current activation, possibly through direct interaction with the site 3 receptor of the Na + channel. No significant effect of AdE-1 on the Ca 2 + current was observed, but, unexpectedly, AdE-1 significantly increased the amplitude of the transient component of the K + current, shifting the current threshold to more negative membrane potentials. This effect on the K + current has not been found in any other sea anemone toxin and may explain the exclusive reduction in action potential amplitude and the absence of the action potential disorders found with other toxins, such as early and delayed afterdepolarizations.
INTRODUCTION

Sea anemone toxins acting on voltage-gated Na
+ channels have been intensively studied in recent years, with over 50 such toxins identified [1] [2] [3] . The main groups of these toxins are type 1 and 2 Na + channel toxins. These share the same scaffold structure containing three S-S bonds and a number of amino acids in conserved sites. Sea anemone Na + channel toxins are thought to bind to Na + channel receptor site 3. They thus interfere with the normal gating of the channel, modifying the response of the voltage sensor in domain 4 (IV-S4) to membrane voltage and uncoupling Na + channel activation from inactivation [4] . This delays Na + current inactivation, thus prolonging the Na + current and, thereby, the AP (action potential) [5] . Prolonging the AP and increasing the cytosolic Na + concentration increases Ca 2 + influx through activation of voltage-dependent Ca 2 + channels and through the Na + /Ca 2 + exchanger. This increases the release of Ca 2 + from the sarcoplasmic reticulum, increasing the transient cytosolic free Ca 2 + concentration ([Ca 2 + ] I ) and, as a result, the cell contractility [6, 7] . These toxins thus provide an example of modification of cell contractility through modifying cell excitation.
The cardiotonic peptide AdE-1 isolated from the sea anemone Aiptasia diaphana [8] shows several chemical and physiological differences from other cnidarian toxins. Although AdE-1 has the same cysteine residue arrangement as sea anemone type 1 and 2 Na + channel toxins, its sequence contains many substitutions in conserved sites and in sites considered essential for bioactivity.
Its overall homology with identified toxins is low (<36 %) [8] . Yet, despite its structural differences, the effectiveness of AdE-1 is comparable with that of Av2 (Anemonia viridis toxin II), a type 1 Na + channel toxin from A. viridis with a similar ED 50 tested on blowfly larvae.
AdE-1 greatly increases the twitch amplitude of cardiomyocytes and slows the late phase of twitch relaxation, but does not induce spontaneous twitching [8] . This effect of AdE-1 on cardiomyocyte contraction dynamics is likely to be due to its modulation of the excitation properties of the cell. It increases the duration of the cardiomyocyte AP with no significant effect on AP threshold and on the resting potential of the cell [9] . In a similar manner to other sea anemone Na + channel toxins such as Av2, AdE-1 markedly inhibits Na + current inactivation of hNav1.5 channels expressed in Xenopus laevis oocytes with no significant effect on current activation, suggesting a similar mechanism of action [10, 11] .
In addition to these characteristic effects of sea anemone Na + channel toxins, AdE-1 shows several unique effects on cardiomyocytes. It decreases AP amplitude and time-to-peak without inducing either early or delayed after-depolarizations, as do Av2 and other sea anemone Na + channel toxins [8, 12, 13] . Additionally, it does not induce spontaneous twitches and irregular rhythm in stimulated adult cardiomyocytes [8] . This toxin thus shows potential for therapeutic use. To determine the mechanisms of the physiological effects of AdE-1 on cardiomyocytes, we focused in the present study on characterizing its effects on the various ion currents in intact cardiomyocytes.
EXPERIMENTAL
Isolating and maintaining adult rat cardiomyocytes
The use of animals in the experiments conformed to the protocols and ethical standards set by the Committee of the Hebrew University of Jerusalem for Animal Care and Use under License number NS-02-13. We slightly modified the protocol for isolation of adult rat cardiomyocytes kindly provided by Professor Philip Palade (Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR, U.S.A.). At 30 min before anaesthesia, 175-250 g adult male Sprague-Dawley rats were injected intraperitoneally with heparin (0.5 ml, 1000 USP units/ml). The rats were anaesthetized by intraperitoneal injection of ketamine/xylazine (8.5 mg of ketamine/100 g of body mass in 0.5 % xylazine). The heart was removed and attached to a cannula connected to a series of condensers containing various solutions (see below for details), warmed to 37
• C and oxygenated with a mixture of 95 % oxygen and 5 % CO 2 . The heart was then subjected to reverse Langendorff perfusion through its aorta at a constant rate of 10 ml/min, first for 2-3 min with modified Tyrode's solution containing 120 mM sodium chloride, 15 mM sodium bicarbonate, 5.4 mM postassium chloride, 5 mM Hepes (sodium salt), 0.25 mM monosodium phosphate, 0.5 mM magnesium chloride and 1 mM calcium chloride (pH 7.4 with sodium hydroxide). The heart was then perfused for 5 min with Ca 2 + -free modified Tyrode's solution. This was followed by perfusion for 10 min with 100 ml of modified Tyrode's solution containing 0.25 mM CaCl 2 , 17 mg of collagenase type II (Worthington) and 0.8 mg of protease type XIV (Sigma). The heart was then removed from the cannula and the ventricles removed and soaked in 3 ml of KB solution [70 mM potassium hydroxide, 50 mM glutamic acid, 40 mM potassium chloride, 20 mM taurine, 20 mM monopotassium phosphate, 10 mM glucose, 10 mM Hepes, 0.5 mM EGTA and 3 mM magnesium chloride (pH 7.4 with potassium hydroxide)]. Ventricles were then cut into small pieces and triturated in a larger volume of KB solution with a wide-bore plastic pipette. The resulting soup-like solution was filtered through silk and the cells were stored in the KB solution at 4-8
• C. Cells were used for experiments for up to 24 h. Only intact rod-shaped cells with clear striation, no micro-blebs and no spontaneous contractions were used.
Determination of the AdE-1 concentration
AdE-1 was prepared as described previously [8] . AdE-1 concentrations were determined by measuring the UV absorption at 228 and 234 nm. The concentration was then calculated using the following equation (eqn 1):
where K = 65.5 and is the slope constant determined by the linear calibration curve with known increasing concentrations of Av2.
Electrophysiological recordings
All experiments were performed at room temperature (∼25 • C) during continuous superfusion. A homemade system for rapid solution changes allowed application of perfusion solution or drugs in the close vicinity of the cells. All measurements were performed with an Axoclamp 2B amplifier (Axon Instruments). Patch pipettes were pulled on a pp-830 puller (Narishige) with a two-step procedure. Pipette resistances were 2-4 M .
Measurement of the cardiomyocyte AP
APs of rat ventricular cardiomyocytes were measured using the whole-cell single-electrode patch-clamp and current-clamp techniques in a bridge mode. After establishing the wholecell configuration, the APs were elicited by current injection (pulse duration 2 ms, amplitude 3-5 nA, 0.2 Hz) from a holding potential of − 90 mV. The superfusion solution contained 150 mM sodium chloride, 5.4 mM potassium chloride, 10 mM Hepes, 2 mM magnesium chloride, 2 mM calcium chloride and 20 mM glucose (pH 7.4). The pipette solution contained 40 mM potassium chloride, 8 mM sodium chloride, 100 mM D,L-Kaspartate, 5 mM magnesium-ATP, 5 mM EGTA, 2 mM calcium chloride, 10 mM Hepes and 0.1 mM Tris-GTP (pH 7.4).
Measurement of cardiomyocyte currents
All measurements of cardiomyocyte currents were performed in whole-cell discontinuous single-electrode voltage-clamp mode. The sampling rate of the discontinuous voltage-clamp was 7-10 kHz.
The Na + current was evoked by 10 mV incrementing steps (50 ms) from the holding potential of − 90 mV up to + 30 mV. The current amplitude was determined as the difference between the peak inward current and the current at the end of the depolarizing step. Cs + , 4-aminopyridine and TEA-Cl (tetraethyl ammonium chloride) were added to block K + currents, and Ca 2 + currents were blocked by cobalt chloride. The experiments were performed with the following superfusion solution: 125 mM TEA-Cl, 5 mM sodium chloride, 5 mM caesium chloride, 20 mM Hepes, 0.5 mM calcium chloride, 1.2 mM magnesium chloride, 3 mM 4-aminopyridine, 0.5 mM cobalt chloride and 11 mM glucose (pH 7.4 adjusted with caesium hydroxide). The pipette solution contained 125 mM caesium hydroxide, 125 mM aspartic acid, 20 mM TEA-Cl, 10 mM Hepes, 5 mM magnesium-ATP, 3.6 mM Na 2 -phosphocreatine and 10 mM EGTA (pH 7.2 adjusted with caesium hydroxide).
L-type Ca 2 + current (I CaL ) was evoked by 10 mV incrementing voltage steps for 50 ms from a holding potential of − 40 mV up to + 60 mV. The current amplitude was determined as the difference between the peak inward current and the current after complete inactivation at the end of the depolarizing step. Current was measured in Na + -free external solution to isolate I CaL from contaminating Na + currents. K + currents were blocked by replacing K + with Cs + . The Na + -free superfusion solution contained 120 mM TEA-Cl, 10 mM caesium chloride, 10 mM Hepes, 2 mM calcium chloride, 1 mM magnesium chloride and 20 mM glucose (pH 7.4 adjusted with caesium hydroxide). The pipette solution contained 90 mM caesium methanesulfonate, 20 mM caesium chloride, 10 mM Hepes, 4 mM magnesium-ATP, 0.4 mM Tris-GTP, 10 mM EGTA and 3 mM calcium chloride (pH 7.2 adjusted with caesium hydroxide). between the peak outward current and the current at the end of the depolarizing step. The currents were measured as the total cardiomyocyte K + current with no physical attempt to distinguish among the various K + currents. To block the Na + currents, the bathing solution contained a low concentration of Na + and 50 μM TTX (tetrodotoxin, Alomone Labs). Ca 2 + currents were blocked by cadmium chloride. The perfusion solution was 140 mM choline-Cl 2 , 10 mM sodium chloride, 5.4 mM potassium chloride, 5 mM Hepes, 1 mM calcium chloride, 1 mM magnesium chloride, 0.3 mM cadmium chloride, 0.05 mM TTX and 5 mM glucose (pH 7.4, adjusted with potassium hydroxide). The pipette solution contained 120 mM D,L,K-aspartate, 30 mM potassium chloride, 1 mM magnesium chloride, 1 mM calcium chloride, 10 mM Hepes, 4 mM magnesium-ATP and 10 mM EGTA (pH 7.2 adjusted with potassium hydroxide).
Data storage and analysis
Data were sampled at 20 kHz. A software program written in Labview (National Instruments) was used to store and analyse data.
Capacitance was measured by integrating the capacitive current of a 10 mV voltage step command at a relatively low clamping gain and dividing it by the amplitude of the voltage step.
Conductance was calculated according to the electrochemical gradient using the following equation (eqn 2):
where g (ion) is the conductance of a specific ion, I (ion) is the current of this ion, V m is the membrane potential and E (ion) is the reversal potential for the ion calculated according to the Nernst equation (eqn 3):
where E (ion) is the reversal potential for the specific ion, C e and C i are the concentrations of the specific ion in the bathing and electrode solutions (respectively) and T is the temperature (298 • K). Sigmoidal activation curves were fitted to the experimental data using the Boltzmann equation in the following form (eqn 4): 
where g v is the conductance at a specific membrane potential, g (max) is the maximum conductance, V (1/2) is the voltage of halfactivation, and k is a slope factor. The data for the Boltzmann function were fitted to each experiment and the extracted parameters averaged. The Na + current inactivation time constants were calculated by first fitting an exponential decay to the slower inactivation phase (τ 2 ) using the following equation (eqn 5):
The faster time constant (τ 1 ) was then extracted using peeling methods [14] .
Statistics
Data were processed using Excel (Microsoft) and are presented as means + − S.E.M. Statistical differences were evaluated by the twotailed paired Student's t test. A value of P < 0.05 was considered statistically significant.
RESULTS
AdE-1 modifies the AP configuration in a complex manner
To explore the effects of AdE-1 on cell excitation we first analysed the dose-response effects on the AP parameters. As described previously [8] , AdE-1 dramatically increased AP duration. Superimposing AP traces recorded after the application of different AdE-1 concentrations revealed the robust concentrationdependent effect of AdE-1 on AP duration (Figures 1A and   1B ). This increase in AP duration was accompanied by dynamic changes in three distinct slopes of the decay phase of the AP (notch, fast and slow; Figure 1C ). These parameters were useful for assessing the dose-dependent effects of AdE-1 on the AP plateau phase. As can be seen in Figure 1(D) , the fast slope declined to a slow steady-state level at AdE-1 concentrations of 2-4 nM, whereas a slow slope, characteristic of the final long plateau phase, appeared at concentrations higher than ∼10 nM. This effect showed no significant dependency on higher AdE-1 concentrations. The effect on the notch slope showed a negative dependency on AdE-1 concentration, tending to vanish at concentrations higher than ∼20 nM.
In contrast with the biphasic concentration-dependent effect of AdE-1 on AP peak amplitude, the amplitude of the plateau potential measured at half AP duration reached a fixed level at approximately 2 nM. It showed no further change with increasing AdE-1 concentration up to 83.5 nM, the maximal concentration tested in the present study ( Figure 1E ). This discrepancy suggests that different mechanisms underlie these two phenomena. The most remarkable and complex concentrationdependent modifications of AP configuration occur with AdE-1 concentration up to approximately 4 nM. This prompted us to analyse the effect of this range of toxin concentrations on the Na + , K + and Ca 2 + currents.
AdE-1 increased Na + currents of isolated cardiomyocytes
AdE-1 greatly affected the pharmacologically isolated Na + current of the cardiomyocytes, increasing the peak amplitude and dramatically inhibiting Na + current inactivation (compare Figures 2A and 2B ). As shown in Figure 2 The effect of AdE-1 on Na + current time-to-peak and on its dependency on membrane potential. AdE-1 slightly increased time-to-peak, but the difference was not significant. (C) The effect of AdE-1 on the cardiomyocyte I − V curve of peak Na + current. The subtraction line (squares) shows the average and S.E.M. of the paired differences between the currents (n = 11). Note the significant differences of the subtracted values from zero (broken line). Results are means + − S.E.M, n = 11. *P < 0.05 was considered statistically significant (two-tailed paired Student's t test).
cell capacitance) from − 12.80 + − 2.63 pA/pF to − 15.86 + − 2.71 pA/pF (P < 0.01, n = 11) and prolonged the half-inactivation time by ∼10-fold (from ∼1.1 ms to ∼11.25 ms). This enormously enhanced the quantity of Na + ions entering the cell. For example, after the application of AdE-1 (2 nM), the total Na + charge (normalized to cell capacitance) entering the cell during a voltage step from a holding potential of − 90 mV to − 30 mV increased from 52.07 + − 9.58 nC/pF to 164.79 + − 30.27 nC/pF (P < 0.01, n = 11; Figure 2D ). This may have important functional consequences because increases in the intracellular concentration of Na + may influence cardiomyocyte contractility (see the Discussion).
Scaling the peak current amplitude emphasized the robust inhibition of current inactivation and the lack of significant effects on current activation ( Figure 3A) . Accordingly, there appeared to be no significant effect on the current time-to-peak ( Figure 3B ) and on the dynamics of the peak current/voltage relationship ( Figure 3C ). These findings indicate a lack of significant effect on current activation, but an increase in its maximal conductance.
We next investigated the effect of the toxin on the dynamics of voltage-dependent activation of the Na + conductance (eqn 2). The parameters of the activation dynamics were extracted and a sigmoidal Boltzmann function was fitted to the conductance data (eqn 4 and Figure 4A ). Fitting the results described above, there was a non-significant effect on the curve parameters; the V (1/2) shifted slightly from − 43.89 + − 1.86 to − 43.23 + − 1.69 mV (P 0.56, n = 11) and the slope factor k from 4.60 + − 0.28 to 4.50 + − 0.28 mV (P 0.70, n = 11). The only significant effect of AdE-1 on the Na + activation curve parameters was the increase in g max from 402.17 + − 93.35 to 481.50 + − 94.78 μS/mF (P 0.001, n = 11; Figure 4C ). This was most probably due to AdE-1 inhibition of current inactivation. This conclusion is supported by further kinetic analysis of the current inactivation. Figure 3 (A) shows a discontinuity in the inactivation process (black arrow). Therefore the slow inactivation cannot be attributed to a single process and is better described by two exponential processes. These two exponential processes were estimated using a peeling method, which revealed a fast (τ 1 ) and a slow (τ 2 ) inactivation time constant in both the control and AdE-1 inactivation kinetics ( Figures 5A and 5B) . However, AdE-1 dramatically enhanced the slow inactivation process by prolonging its time constant (τ 2 ) and increasing the fraction of the current's slow decay phase relative to that of the current's fast decay phase (compare Figure 5A with 5B). We then used the slow time constants of inactivation (τ 2 ) to extrapolate the change which AdE-1 induced in the slow phase of current inactivation ( Figure 5C , dotted line, Δτ 2 ). Subtracting this extrapolated change in slow inactivation from the current after application of AdE-1 ( Figure 5C , grey line, AdE-1) resulted in a current trace [ Figure 5C , dark grey line, (AdE-1) − ( τ 2 )] similar to the current of the control ( Figure 5C , black line, Control). This extrapolation suggested that the major effects of AdE-1 on the Na + current, including the increase in the current peak amplitude, are mediated by its effect on the slow inactivation time constant.
Next we tested the voltage-dependence of these inactivation time constants (from − 50 mV to − 10 mV with 10 mV steps, holding potential − 90 mV) and the values were plotted as a time constant/voltage relationship (τ -v curve, Figure 5D ). Fitting previous work [15] , this calculation showed a negative correlation between the membrane potential and the time constants in the control. Following application of AdE-1 the τ -v curve of the fast inactivation time constant τ 1 did not change. In contrast, the slow time constant τ 2 was much longer and, surprisingly, its voltage-dependency reverted from negative in the control to positive in the presence of the toxin ( Figure 5D ). This phenomenon hints at the mode of channel-toxin interaction (see the Discussion).
AdE-1 did not affect Ca 2 + currents
Enhancement of contraction and prolongation of the AP may also be caused by an increase in Ca 2 + currents. The doseresponse relationship of AdE-1 on AP configuration (Figure 1) showed a clear dynamic effect of AdE-1 on the AP plateau phase up to ∼10 nM. Higher concentrations of AdE-1 had no further significant effect on the level and slopes of the AP plateau potential, suggesting a lack of effect on Ca 2 + current at this higher concentration range. Therefore we tested whether AdE-1 modulates Ca 2 + current at the low concentration (2 nM) at which the toxin exerted the most significant effect on the dynamics of the initial phase of the AP repolarization phase (see Figure 1) . No significant effect of AdE-1 (2 nM) on pharmacologically isolated L-type Ca 2 + current was observed, except for a small and insignificant decrease that did not recover on washing out AdE-1 ( Figure 6 ). This effect most probably resulted from the wellknown Ca 2 + current rundown phenomenon commonly observed during whole-cell recording [16] . This explanation was supported by the gradual shift of the Ca 2 + current I-V curve to a more negative potential (Figure 6 ), which correlated better with time than with AdE-1 treatment [16, 17] . Finally, the same phenomenon was observed in a control experiment in which buffer was perfused instead of AdE-1 (results not shown).
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AdE-1 affects K + currents
Cardiomyocyte contraction and AP duration may be increased by inhibition of K + currents. We measured the effects of AdE-1 on whole cardiomyocyte K + current without attempting to distinguish among the various K + currents [18] . Unexpectedly, AdE-1 clearly and significantly increased the outward K + current (compare Figures 7A and 7B ). Scaling the currents before and after application of AdE-1 suggested that the net current affected by the toxin had transient dynamics ( Figure 7C ). AdE-1 amplification of the K + current was clearly concentrationdependent, showing significant but low effects at 2 nM and much more prominent effects at higher AdE-1 concentrations (Figures 7C and 7D) . As with the Na + current, we calculated the effects of AdE-1 on the K + conductance activation and analysed its properties and kinetics by fitting the Boltzmann equation to the experimental data (eqn 4 and Figure 4B ). This revealed more variable effects on the K + conductance and activation than on Na + current activation kinetics. For example, as shown in Figures 4(B) and 4(C), a concentration of 17.3 nM AdE-1 shifted the channel activation threshold to a more hyperpolarized membrane potential, significantly decreased the K + current activation curve V (1/2) from 17.07 + − 2.27 mV to 12.32 + − 2.72 mV (P 0.005, n = 4), decreased the slope factor k from 12.36 + − 0.46 to 10.39 + − 0.54 (P 0.044, n = 4) and increased the current g max from 84.77 + − 12.59 to 130.44 + − 23.97 μS/mF (P 0.028, n = 4). No effect on K + inactivation was observed. All AdE-1 effects were reversible after perfusion with physiological solution.
DISCUSSION
AdE-1 enhanced both Na + current and transient K + currents of isolated rat cardiomyocytes. This mutual enhancement is an extraordinary phenomenon; to the best of our knowledge there is no other sea anemone toxin nor any other animal toxin which enhances both Na + and K + currents in this manner [19] [20] [21] . Our biophysical characterization suggests different mechanisms of action on Na + and K + currents. The main effect on Na + current was a dramatic inhibition of its inactivation process without affecting its activation kinetics (Figures 2-4) . In contrast, AdE-1 sped up the transient K + current activation by causing a negative potential shift in the activation curve and increasing maximal conductance, with no effect on the current inactivation.
The mode of interaction of AdE-1 with the Na + channel
As mentioned above, AdE-1 inhibited the Na + current inactivation and increased its amplitude with no significant effects on current threshold, rate of current activation and time-topeak. These results suggest that the mechanism underlying the effects of AdE-1 on Na + current is the classic mechanism of sea anemone Na + channel toxins, in which the toxins interact with the channel's site 3 receptor and inhibit the channel's transition to the inactivation state, thus mainly increasing the late component of the Na + current [3, 11] . Indeed, as Figure 5 (C) shows, the major changes in Na + current dynamics, including the increase in peak amplitude, can be attributed to the marked inhibition of the late inactivation phase of the Na + current induced by AdE-1.
The effect on Na + inactivation was accompanied by an effect on the inactivation voltage (τ -v)-dependency. Typically for Na + current inactivation time constants in ventricular myocytes, the fast time constant (τ 1 ), both in control and with the toxin, showed a negative-dependency on membrane potential, i.e. speeding up at more depolarized potentials [15] . However, although the slow time constant (τ 2 ) in the control showed a negative voltagedependency, the slow time constant (τ 2 ) in the presence of the toxin demonstrated a profound and unusual positive-dependency on membrane potential ( Figure 5D ). This effect of AdE-1 on the voltage-dependence of inactivation may be due to voltagedependent toxin binding, with binding increasing at positive membrane potentials. This explanation contradicts previous work on the interaction kinetics of sea anemone Na + channel toxins with their channel targets, which suggested a decrease in toxin affinity at more positive membrane potentials [11] . If this explanation holds, then the AdE-1 interaction with the Na + channel may be unique, making AdE-1 a novel type of sea anemone Na + channel toxin.
The mode of interaction of AdE-1 with the K + channel
AdE-1 significantly increased the activation and maximal conductivity of the K + current. This can be seen as a leftward shift and increase in slope (i.e. decreases the activation V 1/2 and the slope factor k) and an increase in the maximal conductance of the activation curve ( Figures 4B and 4C ). Taking these effects together with the null effect on the current inactivation kinetics, we conclude that AdE-1 enhanced a transient K + current. Thus the effects of AdE-1 on Na + and K + channels clearly differ. The AdE-1 primary structure shows some similarity (≈25 %) to the primary structures of BDS-I and BDS-II, sea anemone K + channel modifier toxins from A. viridis, which 
modify K
+ channel gating kinetics and voltage-dependence. These toxins slow the activation and inactivation kinetics and shift the V 1/2 for activation to more positive voltages via interaction with voltage-sensing domains [22] . Although AdE-1 modified the K + current in an almost opposite manner, the structural similarity and the mode of action of the BDS toxins allows us to speculate that AdE-1 interacts and modifies K + channels kinetics through a direct interaction with the channel's voltage-sensing domains.
The effect of AdE-1 on AP configuration resulted from its combined effects on Na + and K + currents
Our analysis of the concentration-dependent effects of AdE-1 on the cardiomyocyte AP (Figure 1) suggests that the AdE-1 effects arise through two independent mechanisms with different concentration-dependencies. One mechanism is responsible for reducing AP peak amplitude, the other affects the AP duration and plateau level. The voltage-clamp experiments explain these dose-dependent effects of AdE-1 on AP configuration, as they clearly show that AdE-1 increased both Na + and K + currents without affecting Ca 2 + current. This should have a contrasting effect on the AP waveform. The most robust effect of the toxin was to slow the Na + current inactivation, whereas the effect on the K + current was mainly on the activation of a transient current. Thus the AdE-1 effects on Na + and transient K + currents are temporally separated. The AdE-1 effect on the K + current modulates the AP onset, leading to a decrease in peak amplitude, whereas the effect on Na + current inactivation leads to the dramatic prolongation of the AP. At low concentrations (<2 nM) the toxin effect was mainly mediated via inhibition of Na + current inactivation, thus affecting the duration of the plateau potential, whereas the effect on the transient K + current came into effect at higher doses, leading to the decrease in peak amplitude and explaining the biphasic effect of AdE-1 on AP amplitude ( Figure 1E ).
Another unique property of AdE-1 is that it does not elicit early and delayed after-depolarizations, which usually accompany the AP prolongation elicited by other sea anemone toxins, such as Av2 [13] , that slow only Na + channel inactivation. This property may be related to the additional effect of AdE-1 on K + current activation found in the present study and suggests a potential therapeutic effect for this unique toxin.
Conclusion
The present study aimed to characterize the effects of AdE-1, a cardioactive peptide isolated from the sea anemone A. diaphana, on the biophysical properties of cardiomyocytes and to explain the differences in these effects from those of other sea anemone toxins. The results indicate that AdE-1 prolongs AP duration while reducing AP peak amplitude. We suggest that these two effects are the outcome of a robust AdE-1 inhibition of the Na + current inactivation, a common effect for sea anemone Na + channels toxins. However, the extraordinary additional effect of AdE-1 is the enhancement of transient K + current that explains the reduction in AP peak amplitude. The different concentration-dependent enhancement of two opposing currents, and the fact that AdE-1 affected a fast transient K + current and the slow inactivation of Na + current explain the unique temporal effect of this toxin on the initial and late phases of the AP.
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